Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Redrawing the Dividing Line in Nonradiographic axSpA Rob Volansky
• EULAR Launches COVID-19 Rheumatic Disease Reporting Database Jason Laday
• FDA Allows Emergency Use of Blood Purification Technology to Treat Cytokine Storm in COVID-19 Darlene Dobkowski, MA
• FDA Approves Hydroxychloroquine New Drug Application to Address COVID-19 Related Shortage Jason Laday
• FDA Approves Store Brand Equivalent of Voltaren Jason Laday
• FDA Grants Fast Track Status to Telitacicept for SLE Robert Stott
• FDA Clears Novartis to Open Hydroxychloroquine Trial for COVID-19 Jason Laday
• The Rheumatologist and Medical Education in the Time of COVID-19 Leonard H. Calabrese, DO
• Breathing ‘Rheum’ in COVID-19 Hotspots: New Orleans Finds New ‘Camaraderie’ Amid Economic Bust Rob Volansky
• FDA’s Hydroxychloroquine Emergency Use Order for COVID-19 Draws Mixed Reactions Jason Laday
• Rheumatologists, Pharmacists Debate ‘Right to Try’ Hydroxychloroquine for COVID-19 Rob Volansky
• ACR: Suspend Immunosuppressants, Select DMARDs in Rheumatic Patients With COVID-19 Jason Laday
• Updated EULAR Recommendations Revamp Treatment Targets for Lupus Nephritis Jason Laday
• Systemic Lupus Erythematosus Curbside Consults: Managing a Patient With Renal Involvement
• Abortion Does not Worsen Rheumatic Disease Outcomes Jason Laday
• Childhood Sexual, Physical Abuse Increases Adulthood Lupus Risk Among Black Women Jason Laday
• COVID-19 Global Rheumatology Alliance Discourages Off-label Use of Hydroxychloroquine Jason Laday
• Neither First Nor Second Biologic Beneficial for Many With JIA Jason Laday
• Sprifermin Increases Cartilage Thickness, Reduces Loss in Knee OA Jason Laday
• Rheumatologists Move ‘Front and Center’ in Fight Against COVID-19 Rob Volansky
• COVID-19 Threatens Rheumatology Practices Amid Plunging Patient Volume, Revenue Robert Stott
• From the Throat to the Heart: Charting the Long History of Rheumatic Fever Rob Volansky
• Arthritis Foundation’s ‘Live Yes!’ Leverages Patient Input to Enhance Arthritis Trials, Potential Therapies Rob Volansky
• Weathering the Cytokine Storm in COVID-19: Telltale Signs, Therapeutic Hope on the Horizon Rob Volansky
• ACR Calls for Eliminating Redundancies in Prior Authorization Jason Laday
• Asthma, COPD Linked With Increased Risk for RA in Women Jason Laday
• Glucocorticoids, Not Biologics, Increase Adverse Outcome Risk After Major Surgery in RA Jason Laday
• Physical Therapy Superior to Glucocorticoid Injection for OA Pain, Functional Disability Jason Laday